Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the impact of Yueju Pill on quality of life and treatment efficacy in patients with advanced biliary tract cancer (BTC) receiving standard therapy.
Phase:
NA
Details
Lead Sponsor:
Fudan University
Collaborators:
Minhang Central Hospital Shanghai Geriatric Medical Center Shanghai Zhongshan Hospital Xuhui Central Hospital, Shanghai